
Massive Pharmaceutical Company Set to Acquire ’23 And Me’ And It’s Genetic Data
Regeneron Pharmaceuticals is buying personal genomics company 23andMe for $256 million following a bankruptcy auction. This move gives Regeneron access to one of the largest private genetic databases in the world—raising big questions about privacy, …